重组Anti-Met (c-Met) (phospho Y1349)抗体[EP2367Y]
Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y]
- RabMAb
- Recombinant
- 了解详情
4
(6 Reviews)
|
(25 Publications)
Rabbit Recombinant Monoclonal Met (c-Met) phospho Y1349 antibody. Suitable for IP, Dot, WB, IHC-P and reacts with Human, Synthetic peptide samples. Cited in 25 publications.
查看别名
Hepatocyte growth factor receptor, HGF receptor, HGF/SF receptor, Proto-oncogene c-Met, Scatter factor receptor, Tyrosine-protein kinase Met, SF receptor, MET
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using ab68141 at a dilution of 1/50.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
ab68141 at 1/150 dilution immunoprecipitating Met (c-Met) (phospho Y1349) in HeLa (human cervix adenocarcinoma) whole cell lysate observed at 150 kDa (lanes 1 and 2).
Lane 1 (input) : HeLa cells starved for 24 hours, then treated with 40 ng/mL HGF for 5 minutes whole cell lysate, 10μg
Lane 2 (+) : ab68141 + HeLa cells starved for 24 hours, then treated with 40 ng/mL HGF for 5 minutes whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab68141 in HeLa cells starved for 24 hours, then treated with 40 ng/mL HGF for 5 minutes whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Blocking and Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)
Predicted band size: 155 kDa
false
Exposure time: 3s
- WB
Unknown
Western blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
All lanes:
Western blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141) at 1/10000 dilution
Lane 1:
A431 cell lysate, untreated at 10 µg
Lane 2:
A431 cell lysate, treated with AP at 10 µg
Secondary
All lanes:
HRP-labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 155 kDa
Observed band size: ~150 kDa
false
- WB
Lab
Western blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight of Met (c-Met) (phospho Y1349) and Met (c-Met) is different. ab51067 could only recognize the pro-Met which is 190kDa, but ab68141 recognizes theβ-subunits which is 145kDa.
All lanes:
Western blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141) at 1/5000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) serum starved for 24 h. Whole cell lysates at 15 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) serum starved for 24 h and then treated with hepatocyte growth factor at 40ng/ml for 5 min. Whole cell lysates at 15 µg
Lane 3:
HeLa (Human cervix adenocarcinoma epithelial cell) serum starved for 24 h and then treated with hepatocyte growth factor at 40ng/ml for 5 min. Whole cell lysates. Then the membrane was incub at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 155 kDa
Observed band size: 150 kDa
false
Exposure time: 30s
- Dot
Unknown
Dot Blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
Dot blot analysis of Met (c-Met) (phospho Y1349) phospho peptide (Lane 1) Met (c-Met) Non-phospho peptide (Lane 2) labelling Met (c-Met) (phospho Y1349) with ab68141 at a dilution of 1/1000. Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/2500.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
- WB
CiteAb
Western blot - Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (AB68141)
Met (c-Met) (phospho Y1349) western blot using anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] ab68141. Publication image and figure legend from Zhao, Q., Zhu, H. P., et al., 2020, Int J Mol Sci, PubMed 32156008.
ab68141 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab68141 please see the product overview.
(A) Cells were incubated with various concentrations (0, 20, or 40 μg/mL) of DHP1808 for 24 h. Expression or phosphorylation levels of HSP90 client proteins were determined by western blot analysis; (B) Cells were incubated with various concentrations (0, 20, or 40 μg/mL) of DHP1808 for 24 h. Expression or phosphorylation levels of proteins associated with MAPK signaling pathway were determined by western blot analysis; (C) Cells were incubated with various concentrations (0, 20, or 40 μg/mL) of DHP1808 for 24 h. Expression or phosphorylation level of proteins associated with the PI3K-Akt signaling pathway was determined by western blot analysis; (D). The fold change of EGFR expression was determined by qPCR analysis.
false
不同偶联物与剂型 (1)
-
Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] - BSA and Azide free
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (25)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 43:103 PubMed38570866
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 16: PubMed38201620
2024
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology 38:1487-1498 PubMed37140169
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 21:462-476 PubMed35100091
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:17 PubMed35013115
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 41:997-1010 PubMed34974522
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:11157-11169 PubMed34761497
2021
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 11:3115-3125 PubMed34555268
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34575841
2021
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2021:5574555 PubMed34408780
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com